Type 1 Diabetes – Insulin Treatment

Medical Condition: Type 1 Diabetes

Facility/Clinic: Accellacare

Age: 18 or older

Gender: Male/Female

Description: We are doing this study to find out how well insulin icodec controls blood sugar compared to insulin degludec in people with type 1 diabetes also taking a marketed mealtime insulin (insulin aspart). Insulin icodec is a new insulin taken once-weekly on the same day each week. Insulin degludec is an insulin already available on the market, taken once-daily, preferably at the same time each day. This research study may be an option if you:

  • Have been diagnosed with Type 1 Diabetes for at least 1 year
  • Have been treated with multiple daily insulin injections for at least 1 year
  • Have not had a heart attack or stroke within the last 180 days
  • Are not diagnosed with Class IV Chronic Heart Failure
  • Do not have a planned Coronary, Carotid or Peripheral Artery revascularization

Other criteria apply. Please make sure to discuss with a member of our research staff to ensure this study is a good fit for you. Qualified participants will receive all study-related care and study medication at no cost.

Enrollment: Open

Patient Commitment Duration: Approximately 1 year and 2 months

Number of visits in study: Approximately 28 clinic visits and 28 phone calls

Patient Compensation: Financial compensation will be provided for time and travel expenses.

The team at WH Research can guide interested clinical research participants through the process of enrolling in a trial.
Please call 910-362-4040 between the hours of 8am-5pm for general research questions.